Home
About
Services
Partners
Client Portfolio
News
Contact
Biggest U.S. banks says they submitted $45.8 billion in loans for emergency aid program
April 30, 2020
Amgen studying Otezla for coronavirus, looking into other treatments
April 30, 2020
0
Gilead to work with partners to ramp up production of potential coronavirus treatment
Published by
Muller&Green
at
April 30, 2020
Categories
RSS
Tags
Gilead Sciences Inc, maker of the closely-watched experimental coronavirus drug remdesivir, on Thursday said it will work with international partners to expand production of the potential COVID-19 treatment.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more